{"organizations": [], "uuid": "1b6d45da73c34f04fa4f431277c6af950b7c1dd3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180108.html", "section_title": "Archive News &amp; Video for Monday, 08 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-amicus-therapeutics-expects-2018-n/brief-amicus-therapeutics-expects-2018-net-cash-spend-of-230-mln-to-260-mln-idUSL8N1P3398", "country": "US", "domain_rank": 408, "title": "BRIEF-Amicus Therapeutics Expects 2018 Net Cash Spend Of $230 Mln To $260 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.289, "site_type": "news", "published": "2018-01-08T22:13:00.000+02:00", "replies_count": 0, "uuid": "1b6d45da73c34f04fa4f431277c6af950b7c1dd3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-amicus-therapeutics-expects-2018-n/brief-amicus-therapeutics-expects-2018-net-cash-spend-of-230-mln-to-260-mln-idUSL8N1P3398", "ord_in_thread": 0, "title": "BRIEF-Amicus Therapeutics Expects 2018 Net Cash Spend Of $230 Mln To $260 Mln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "amicus therapeutics inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "dec", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 8 (Reuters) - Amicus Therapeutics Inc:\n* AMICUS THERAPEUTICS PROVIDES FULL-YEAR 2018 STRATEGIC OUTLOOK AND FINANCIAL GUIDANCE\n* AMICUS THERAPEUTICS SEES GALAFOLD FY 2018 REVENUE $75 MILLION TO $85 MILLION\n* CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES TOTALED ABOUT $359 MILLION AT DEC 31, 2017\n* EXPECTS FULL-YEAR 2018 NET CASH SPEND OF BETWEEN $230 MILLION AND $260 MILLION\n* CURRENT CASH POSITION IS ANTICIPATED TO FUND ONGOING OPERATIONS INTO AT LEAST SECOND HALF OF 2019\n* FY2018 REVENUE VIEW $88.9 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-08T22:13:00.000+02:00", "crawled": "2018-01-09T16:49:29.018+02:00", "highlightTitle": ""}